Corvus Pharmaceuticals Inc (CRVS)
1.97
+0.26
(+15.20%)
USD |
NASDAQ |
May 08, 16:00
2.00
+0.03
(+1.52%)
After-Hours: 18:59
Corvus Pharmaceuticals Price: 1.97 for May 8, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 07, 2024 | 1.81 | 1.94 | 1.43 | 1.71 | 937458.0 |
May 06, 2024 | 2.09 | 2.09 | 1.83 | 1.91 | 1.050M |
May 03, 2024 | 1.81 | 2.08 | 1.75 | 1.92 | 381059.0 |
May 02, 2024 | 1.76 | 1.78 | 1.68 | 1.73 | 453252.0 |
May 01, 2024 | 1.53 | 1.647 | 1.51 | 1.61 | 80682.00 |
Apr 30, 2024 | 1.60 | 1.60 | 1.53 | 1.55 | 56501.00 |
Apr 29, 2024 | 1.48 | 1.61 | 1.44 | 1.58 | 131930.0 |
Apr 26, 2024 | 1.56 | 1.619 | 1.44 | 1.45 | 124494.0 |
Apr 25, 2024 | 1.47 | 1.52 | 1.410 | 1.48 | 66282.00 |
Apr 24, 2024 | 1.60 | 1.60 | 1.49 | 1.51 | 90571.00 |
Apr 23, 2024 | 1.43 | 1.57 | 1.43 | 1.53 | 137350.0 |
Apr 22, 2024 | 1.39 | 1.50 | 1.39 | 1.44 | 130642.0 |
Apr 19, 2024 | 1.40 | 1.44 | 1.36 | 1.40 | 58804.00 |
Apr 18, 2024 | 1.38 | 1.45 | 1.30 | 1.41 | 140418.0 |
Apr 17, 2024 | 1.50 | 1.510 | 1.36 | 1.36 | 112527.0 |
Apr 16, 2024 | 1.44 | 1.51 | 1.36 | 1.47 | 91660.00 |
Apr 15, 2024 | 1.53 | 1.536 | 1.41 | 1.47 | 69358.00 |
Apr 12, 2024 | 1.60 | 1.620 | 1.50 | 1.53 | 155480.0 |
Apr 11, 2024 | 1.61 | 1.61 | 1.520 | 1.56 | 122961.0 |
Apr 10, 2024 | 1.67 | 1.67 | 1.46 | 1.51 | 231063.0 |
Apr 09, 2024 | 1.71 | 1.78 | 1.60 | 1.63 | 196127.0 |
Apr 08, 2024 | 1.75 | 1.790 | 1.68 | 1.71 | 120413.0 |
Apr 05, 2024 | 1.68 | 1.78 | 1.63 | 1.75 | 190703.0 |
Apr 04, 2024 | 1.77 | 1.85 | 1.685 | 1.69 | 211179.0 |
Apr 03, 2024 | 1.83 | 1.86 | 1.73 | 1.75 | 490276.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6481
Minimum
Mar 28 2023
8.53
Maximum
Sep 21 2021
2.617
Average
2.475
Median
Price Benchmarks
Cyclacel Pharmaceuticals Inc | 2.35 |
Arbutus Biopharma Corp | 2.83 |
Oragenics Inc | 1.22 |
Relmada Therapeutics Inc | 3.85 |
MAIA Biotechnology Inc | 3.02 |
Price Related Metrics
Price to Book Value | 2.497 |
Earnings Yield | -28.43% |
Market Cap | 96.61M |